Literature DB >> 27941339

Overexpression of CXCR7 Is a Novel Prognostic Indicator in Gastric Cancer.

Sho Nambara1, Tomohiro Iguchi, Eiji Oki, Patrick Tan, Yoshihiko Maehara, Koshi Mimori.   

Abstract

BACKGROUND: Among several candidate genes that promote peritoneal dissemination extracted by comprehensive expression analysis of both in vivo selected metastatic cell lines and patients with gastric cancer, we focused on the chemokine (C-X-C motif) receptor (CXCR7) and explored its clinicopathological significance in gastric cancer.
METHODS: CXCR7 expression was evaluated by microarray data in the Singapore cohort (n = 196) and by immunohistochemistry and reverse transcription quantitative real-time polymerase chain reaction in the Japanese cohort (n = 195). The biological function of CXCR7 in gastric cancer was explored using gene set enrichment analysis (GSEA).
RESULTS: CXCR7 expression was upregulated in tumor tissues compared to normal tissues. High CXCR7 mRNA expression was associated with peritoneal dissemination and poor prognosis in the Singapore cohort. Consistent with this, the high CXCR7 mRNA expression group showed significantly poorer prognosis and a more aggressive disease course than the low expression group in the Japanese cohort. High CXCR7 mRNA expression and peritoneal dissemination were clinically relevant. GSEA revealed that CXCR7 was significantly enriched in gene expression signatures associated with tumor progression.
CONCLUSIONS: CXCR7 may be a prognostic indicator and therapeutic target for gastric cancer with peritoneal dissemination.
© 2016 S. Karger AG, Basel.

Entities:  

Keywords:  CXCR7; Gastric cancer; Peritoneal dissemination; Prognostic factor

Mesh:

Substances:

Year:  2016        PMID: 27941339     DOI: 10.1159/000452977

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  12 in total

1.  MicroRNA-100 suppresses human gastric cancer cell proliferation by targeting CXCR7.

Authors:  Yongfeng Cao; Jiaye Song; Jianjuan Ge; Zhuchen Song; Jia Chen; Changping Wu
Journal:  Oncol Lett       Date:  2017-10-31       Impact factor: 2.967

2.  Decursin inhibits tumor growth, migration, and invasion in gastric cancer by down-regulating CXCR7 expression.

Authors:  Solbi Kim; Ji-Eun Kim; Nayoung Kim; Mina Joo; Myung-Won Lee; Heung Jin Jeon; Hyewon Ryu; Ik-Chan Song; Gyu-Yong Song; Hyo Jin Lee
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

Review 3.  Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma.

Authors:  Li-Jun Xue; Xiao-Bei Mao; Li-Li Ren; Xiao-Yuan Chu
Journal:  Cancer Med       Date:  2017-05-23       Impact factor: 4.452

4.  Effects of acute exposure to low-dose radiation on the characteristics of human bone marrow mesenchymal stromal/stem cells.

Authors:  Aya Fujishiro; Yasuo Miura; Masaki Iwasa; Sumie Fujii; Noriko Sugino; Akira Andoh; Hideyo Hirai; Taira Maekawa; Tatsuo Ichinohe
Journal:  Inflamm Regen       Date:  2017-09-01

Review 5.  Functions and mechanisms of chemokine receptor 7 in tumors of the digestive system.

Authors:  Qi Xin; Quan Sun; Chuan-Shan Zhang; Qin Zhang; Chun-Jun Li
Journal:  World J Clin Cases       Date:  2020-06-26       Impact factor: 1.337

6.  Prognostic significance of CXCR7 in cancer patients: a meta-analysis.

Authors:  Huiqian Fan; Weijun Wang; Jingjing Yan; Li Xiao; Ling Yang
Journal:  Cancer Cell Int       Date:  2018-12-19       Impact factor: 5.722

7.  CXCR7 Inhibits Fibrosis via Wnt/β-Catenin Pathways during the Process of Angiogenesis in Human Umbilical Vein Endothelial Cells.

Authors:  MinQian Shen; YiFan Feng; Jing Wang; YuanZhi Yuan; Fei Yuan
Journal:  Biomed Res Int       Date:  2020-06-05       Impact factor: 3.411

Review 8.  The Role of Chemokines in the Development of Gastric Cancer - Diagnostic and Therapeutic Implications.

Authors:  Elzbieta Pawluczuk; Marta Łukaszewicz-Zając; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

9.  CD271+, CXCR7+, CXCR4+, and CD133+ Stem/Progenitor Cells and Clinical Characteristics of Acute Ischemic Stroke Patients.

Authors:  Anna Gójska-Grymajło; Maciej Zieliński; Dariusz Gąsecki; Kamil Kowalczyk; Mariusz Kwarciany; Barbara Seroczyńska; Walenty M Nyka
Journal:  Neuromolecular Med       Date:  2018-05-09       Impact factor: 3.843

10.  GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFβR2 in colorectal cancer.

Authors:  Sho Nambara; Takaaki Masuda; Yuta Kobayashi; Kuniaki Sato; Taro Tobo; Kensuke Koike; Miwa Noda; Yushi Ogawa; Yousuke Kuroda; Shuhei Ito; Hidetoshi Eguchi; Keishi Sugimachi; Koshi Mimori
Journal:  Cancer Sci       Date:  2019-12-27       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.